News
The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...
2d
24/7 Wall St. on MSNPfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13 years. Shares are down 19% over the ...
We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...
These household names and index components are yielding better than 4.5% with compelling valuations.
It looks like Pfizer Inc. ( NYSE:PFE ) is about to go ex-dividend in the next two days. The ex-dividend date is ...
The FDA’s Oncologic Drugs Advisory Committee (ODAC) is planning to host its first meeting under new agency commissioner Marty ...
Novel treatment restores natural clotting balance and helps reduce bleeding episodes in people with hemophilia ...
Angela Hwang spent nearly three decades at Pfizer before joining Flagship Pioneering in 2025 as a CEO-partner and the CEO of ...
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
4d
24/7 Wall St. on MSN3 Ultra-High Yield Dividend Stocks to Buy This MayAmid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained ...
Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results